LABORATORY DIAGNOSIS OF THE LIPID SPECTRUM IN MIGRAINE AND ITS RELATIONSHIP WITH CLINICAL CHARACTERISTICS

FULL TEXT:

Abstract

This article discusses changes in the lipid spectrum in patients with migraine. Identified dyslipidemia is considered as a risk factor for vascular complications, regardless of the clinical characteristics of migraine. Elevated HDL levels may play a protective role against vascular complications.

About the Authors

List of references

Lipton RB, Bigal ME. The epidemiology of migraine. Am J Med. 2005;118 (Suppl 1):3S–10S.

Goadsby PJ, Lipton RB, Ferrari MD. Migraine--current understanding and treatment. N Engl J Med. 2002;346:257–70.

Kurth T, Slomke MA, Kase CS, Cook NR, Lee IM, Gaziano JM, et al. Migraine, headache, and the risk of stroke in women: a prospective study. Neurology. 2005;64:1020–6.

MacClellan LR, Giles WH, Cole J, Wozniak MA, Stern B, Mtichell B, Kittner SJ. Probable migraine with visual aura and risk of ischemic stroke: The Stroke Prevention in Young Women Study. Stroke. 2007;38:2438–45.

Schurks M, Rist PM, Bigal ME, Buring JE, Lipton RB, Kurth T. Migraine and cardiovascular disease: systematic review and meta-analysis. BMJ. 2009;339:b3914.

Kurth T, Mohamed S, Maillard P, Zhu YC, Chabriat H, Mazoyer B, et al. Headache, migraine, and structural brain lesions and function: population based Epidemiology of Vascular Ageing-MRI study. BMJ. 2011;342:c7357.

Kurth T, Gaziano JM, Cook NR, Logroscino G, Diener HC, Buring JE. Migraine and risk of cardiovascular disease in women. JAMA. 2006;296:283–91.

Bigal ME, Kurth T, Santanello N, Buse D, Golden W, Robbins M, Lipton RB. Migraine and cardiovascular disease: a population-based study. Neurology. 2010;74:628–35.

Scher AI, Terwindt GM, Picavet HS, Verschuren WM, Ferrari MD, Launer LJ. Cardiovascular risk factors and migraine: the GEM population-based study. Neurology. 2005;64:614–20.

Hamed SA, Hamed EA, Ezz Eldin AM, Mahmoud NM. Vascular risk factors, endothelial function, and carotid thickness in patients with migraine: relationship to atherosclerosis. J Stroke Cerebrovasc Dis. 2011;19:92–103.

Kurth T, Ridker PM, Buring JE. Migraine and biomarkers of cardiovascular disease in women. Cephalalgia. 2008;28:49–56.

Tietjen GE, Herial NA, White L, Utley C, Kosmyna JM, Khuder SA. Migraine and biomarkers of endothelial activation in young women. Stroke. 2009;40:2977–82.

Gruber HJ, Bernecker C, Pailer S, Lechner A, Horejsi R, Moller R, et al. Lipid profile in normal weight migraineurs - evidence for cardiovascular risk. Eur J Neurol. 2010;17:419–25.

Bigal ME. Migraine, lipid profile, and cardiovascular disease. Eur J Neurol. 2010;17:342–3.

Monastero R, Pipia C, Cefalu AB, Liveri ET, Rosano R, Camarda R, Camarda C. Association between plasma lipid levels and migraine in subjects aged > or =50 years: preliminary data from the Zabut Aging Project. Neurol Sci. 2008;29 (Suppl 1):S179–81.

Kurth T, Schurks M, Logroscino G, Gaziano JM, Buring JE. Migraine, vascular risk, and cardiovascular events in women: prospective cohort study. BMJ. 2008;337:a636.

Nozari A, Dilekoz E, Sukhotinsky I, Stein T, Eikermann-Haerter K, Liu C, et al. Microemboli may link spreading depression, migraine aura, and patent foramen ovale. Ann Neurol. 2010;67:221–9.

Views: 63